ERYTECH announces the granting of its core process patent in the United States with two additional years of exclusivity

Post author:admERY
Post published:September 16, 2013
Post category:Newsroom

ERYTECH announces it received notification of allowance for the granting of its core process patent in the United States with two additional years of exclusivity in the United States.

You Might Also Like

ERYTECH Provides Business and Financial Update for the Third Quarter of 2022

ERYTECH Announces Completion of First Cohort in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer

ERYTECH Provides Business and Financial Update for the First Quarter of 2023